SE454299B - Sats innehallande polypeptid som finns i pankreasoamyloid och/eller antikroppar riktade mot polypeptiden - Google Patents

Sats innehallande polypeptid som finns i pankreasoamyloid och/eller antikroppar riktade mot polypeptiden

Info

Publication number
SE454299B
SE454299B SE8604270A SE8604270A SE454299B SE 454299 B SE454299 B SE 454299B SE 8604270 A SE8604270 A SE 8604270A SE 8604270 A SE8604270 A SE 8604270A SE 454299 B SE454299 B SE 454299B
Authority
SE
Sweden
Prior art keywords
iapp
amino acid
ser
protein
human
Prior art date
Application number
SE8604270A
Other languages
English (en)
Swedish (sv)
Other versions
SE8604270D0 (sv
Inventor
Per Westermark
Kenneth H Johnson
Original Assignee
Westermark P
Univ Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20365860&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE454299(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Westermark P, Univ Minnesota filed Critical Westermark P
Priority to SE8604270A priority Critical patent/SE454299B/sv
Publication of SE8604270D0 publication Critical patent/SE8604270D0/xx
Priority to PCT/SE1987/000452 priority patent/WO1988002863A1/en
Priority to ES87850300T priority patent/ES2072252T3/es
Priority to AU81012/87A priority patent/AU8101287A/en
Priority to CA000548777A priority patent/CA1341222C/en
Priority to EP87850300A priority patent/EP0263802B1/de
Priority to JP62506094A priority patent/JP2863527B2/ja
Priority to DE3751316T priority patent/DE3751316T2/de
Priority to AT87850300T priority patent/ATE123147T1/de
Publication of SE454299B publication Critical patent/SE454299B/sv
Priority to US07/516,329 priority patent/US5116948A/en
Priority to US07/658,442 priority patent/US5112945A/en
Priority to US07/838,043 priority patent/US5298605A/en
Priority to US08/183,150 priority patent/US5424221A/en
Priority to JP8199912A priority patent/JP2939439B2/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57525—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the liver or pancreas
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/843—Digestive system
    • Y10S530/845—Pancreas
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/866—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving immunoglobulin or antibody fragment, e.g. fab', fab, fv, fc, heavy chain or light chain

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE8604270A 1986-10-08 1986-10-08 Sats innehallande polypeptid som finns i pankreasoamyloid och/eller antikroppar riktade mot polypeptiden SE454299B (sv)

Priority Applications (14)

Application Number Priority Date Filing Date Title
SE8604270A SE454299B (sv) 1986-10-08 1986-10-08 Sats innehallande polypeptid som finns i pankreasoamyloid och/eller antikroppar riktade mot polypeptiden
AT87850300T ATE123147T1 (de) 1986-10-08 1987-10-07 Materialzusammensetzung, welche ein polypeptid aus pankreas-insel-amyloid und/oder antikörpern gegen dieses polypeptid enthält, und anwendung dieser zusammensetzung.
ES87850300T ES2072252T3 (es) 1986-10-08 1987-10-07 Estuche de material que contiene un polipeptido de amiloide de los islotes y/o anticuerpos dirigidos contra dicho polipeptido, y uso de dicho estuche de material.
EP87850300A EP0263802B1 (de) 1986-10-08 1987-10-07 Materialzusammensetzung, welche ein Polypeptid aus Pankreas-Insel-Amyloid und/oder Antikörpern gegen dieses Polypeptid enthält, und Anwendung dieser Zusammensetzung
DE3751316T DE3751316T2 (de) 1986-10-08 1987-10-07 Materialzusammensetzung, welche ein Polypeptid aus Pankreas-Insel-Amyloid und/oder Antikörpern gegen dieses Polypeptid enthält, und Anwendung dieser Zusammensetzung.
AU81012/87A AU8101287A (en) 1986-10-08 1987-10-07 Kit of material containing a polypeptide of pancreatic islet amyloid and/or antibodies directed against said polypeptide; and use of said kit of material
CA000548777A CA1341222C (en) 1986-10-08 1987-10-07 Preparations of islet amyloid polypeptide (iapp) and antibodies to iapp
PCT/SE1987/000452 WO1988002863A1 (en) 1986-10-08 1987-10-07 Kit of material containing a polypeptide of pancreatic islet amyloid and/or antibodies directed against said polypeptide; and use of said kit of material
JP62506094A JP2863527B2 (ja) 1986-10-08 1987-10-07 膵島アミロイドポリペプチド
US07/516,329 US5116948A (en) 1986-10-08 1990-04-30 Preparations of islet amyloid polypeptide (iapp) and antibodies to iapp
US07/658,442 US5112945A (en) 1986-10-08 1991-02-21 Preparation of islet amyloid polypeptides (iapp) and antibodies to iapp
US07/838,043 US5298605A (en) 1986-10-08 1992-02-19 Antibodies to islet amyloid polypeptide (IAPP) and subunits thereof
US08/183,150 US5424221A (en) 1986-10-08 1994-01-18 Kit for detection of islet amyloid polypeptide (IAPP)
JP8199912A JP2939439B2 (ja) 1986-10-08 1996-07-30 膵島アミロイドポリペプチドに対する抗体

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8604270A SE454299B (sv) 1986-10-08 1986-10-08 Sats innehallande polypeptid som finns i pankreasoamyloid och/eller antikroppar riktade mot polypeptiden

Publications (2)

Publication Number Publication Date
SE8604270D0 SE8604270D0 (sv) 1986-10-08
SE454299B true SE454299B (sv) 1988-04-18

Family

ID=20365860

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8604270A SE454299B (sv) 1986-10-08 1986-10-08 Sats innehallande polypeptid som finns i pankreasoamyloid och/eller antikroppar riktade mot polypeptiden

Country Status (10)

Country Link
US (2) US5116948A (de)
EP (1) EP0263802B1 (de)
JP (2) JP2863527B2 (de)
AT (1) ATE123147T1 (de)
AU (1) AU8101287A (de)
CA (1) CA1341222C (de)
DE (1) DE3751316T2 (de)
ES (1) ES2072252T3 (de)
SE (1) SE454299B (de)
WO (1) WO1988002863A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298605A (en) * 1986-10-08 1994-03-29 Regents Of The University Of Minnesota Antibodies to islet amyloid polypeptide (IAPP) and subunits thereof
US5367052A (en) * 1987-04-27 1994-11-22 Amylin Pharmaceuticals, Inc. Amylin peptides
GB8720115D0 (en) * 1987-08-26 1987-09-30 Cooper G J S Treatment of diabetes mellitus
GB8709871D0 (en) * 1987-04-27 1987-06-03 Turner R C Peptides
US5266561A (en) * 1988-01-11 1993-11-30 Amylin Pharmaceuticals, Inc. Treatment of type 2 diabetes mellitus
US5175145A (en) * 1988-08-26 1992-12-29 Amylin Pharmaceuticals, Inc. Treatment of diabetes mellitus with amylin agonists
HU222249B1 (hu) * 1991-03-08 2003-05-28 Amylin Pharmaceuticals Inc. Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
US5352771A (en) * 1992-08-31 1994-10-04 Iowa State University Research Foundation Inc. Hydrolysis of peptide bonds using Pt (II) and Pd (II) complexes
US5376638A (en) * 1992-09-01 1994-12-27 Amylin Pharmaceuticals, Inc. Methods for treating renin-related disorders with amylin antagonists
WO1996002269A1 (en) * 1994-07-13 1996-02-01 Auckland Uniservices Limited Therapeutic method and compounds of use therein
US6087129A (en) 1996-01-19 2000-07-11 Betagene, Inc. Recombinant expression of proteins from secretory cell lines
US6821954B2 (en) 1997-09-18 2004-11-23 Auckland Uniservices Limited Compounds and uses thereof in treating bone disorders
US6562836B1 (en) * 1999-05-24 2003-05-13 Queen's University Of Kingston Methods and compounds for inhibiting amyloid deposits
WO2006010533A2 (en) * 2004-07-28 2006-02-02 F. Hoffmann-La Roche Ag Pancreatic polypeptide as target/marker of beta cell failure
DE102004051014A1 (de) * 2004-10-20 2006-04-27 Rwth Aachen Chemisch modifizierte Peptidanaloga
JP7505713B2 (ja) * 2019-02-22 2024-06-25 ロヨラ メリーマウント ユニバーシティ アミロイドペプチドバリアント

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE500044C2 (sv) * 1985-02-15 1994-03-28 Gambro Lundia Ab Peptidförening, antiserum framställt med användning av denna förening samt användning av föreningen
GB8516081D0 (en) * 1985-06-25 1985-07-31 Ciba Geigy Ag Assay & purification of amyloid components
GB8709871D0 (en) * 1987-04-27 1987-06-03 Turner R C Peptides

Also Published As

Publication number Publication date
US5112945A (en) 1992-05-12
JPH02500857A (ja) 1990-03-22
ATE123147T1 (de) 1995-06-15
SE8604270D0 (sv) 1986-10-08
EP0263802A1 (de) 1988-04-13
JP2863527B2 (ja) 1999-03-03
AU8101287A (en) 1988-05-06
CA1341222C (en) 2001-05-01
JP2939439B2 (ja) 1999-08-25
JPH09119929A (ja) 1997-05-06
DE3751316D1 (de) 1995-06-29
WO1988002863A1 (en) 1988-04-21
ES2072252T3 (es) 1995-07-16
DE3751316T2 (de) 1996-02-01
EP0263802B1 (de) 1995-05-24
US5116948A (en) 1992-05-26

Similar Documents

Publication Publication Date Title
Westermark et al. Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells.
SE454299B (sv) Sats innehallande polypeptid som finns i pankreasoamyloid och/eller antikroppar riktade mot polypeptiden
Altstein et al. An immunochemical analysis of oxytocin and vasopressin prohormone processing in vivo
CN103298836B (zh) 用于获得抗疏水性肽抗体的抗原的制备方法
JPH0445520B2 (de)
US6638771B1 (en) Composition and method for diagnosing auto-immune hepatitis
Graindorge et al. Radioimmunologic method for detection of antitubular basement membrane antibodies
US5424221A (en) Kit for detection of islet amyloid polypeptide (IAPP)
CN101466732A (zh) Iv型胶原样免疫反应性多肽
CN105137071A (zh) 心肌肌钙蛋白i均相酶免疫法测定试剂盒
Barnard et al. Immunological studies with human aortic elastin
JPH083486B2 (ja) 体液中の基底膜コラーゲンの測定法及び基底膜コラーゲン―ドメインｎｃ１に対する抗体の検出法
Leung et al. Colonic tumor membrane-associated glycoprotein: Isolation of antigenically-active peptides after chemical cleavage
KR100742115B1 (ko) 조피볼락의 다클론 항체를 이용한 성숙도 판정방법
Cocchiara et al. Purification of Par j I, a major allergen from Parietaria judaica pollen
Costopoulou et al. Direct ELISA method for the specific determination of prothymosin alpha in human specimens
Leroy Precipitating and complement-fixing antibodies to collagen with species and collagen subunit specificity
CN116284333B (zh) 一种SjHNF4多肽抗体、制备方法及应用
JP5354158B2 (ja) 抗デカン酸修飾型グレリン抗体、デカン酸修飾型グレリン測定方法、およびデカン酸修飾型グレリン分離回収方法
Lüning et al. Amino acid sequence identity of TPA fragments from different sources
CN115043927A (zh) 针对抗α-突触核蛋白K80Hcy抗体的抗原肽及其应用
SE459372B (sv) Humant pankreasspecifikt protein (hpasp), framstaellning av antikroppar mot proteinet och diagnostiskt foerfarande vid akut pankreatit
WO1996038479A1 (fr) Procede de diagnostic du diabete sucre insulino-dependant et kit de diagnostic
VidaliS Availability of Hyperacetylated H4 Histone in Intact Nucleosomes to Specific Antibodies
Rogol CYANOGEN BROMIDE FRAGMENTS AND PARTIAL AMINO ACID SEQUENCE OF BOVINE GROWTH HORMONE

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8604270-2

Format of ref document f/p: F

NUG Patent has lapsed